Sherine Ismail (Sherin Ismail)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Patients Undergoing

Acinetobacter Baumannii

Top Venues

Journal of the American Society of Nephrology : JASN

Pharmacy (Basel, Switzerland)

Hospital pharmacy

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Tiansheng Wang, Dongze Ji, Til Stürmer, Sherine Ismail, Shujie Dong, Peng Shen, Hongbo Lin, Luwen Shi, Xiaodong Guan, Yang Xu
The Effect of Sodium Glucose Cotransporter-2 Inhibitors on Hemoglobin A1c Variability and Acute Kidney Injury: A Causal Mediation Analysis. Pharmacoepidemiology and drug safety 33 (8) (2024)
Sherine Ismail, Michele Jonsson Funk, Jennifer E Flythe
Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis. Journal of the American Society of Nephrology : JASN (2024)
Sherine Ismail, Michele Jonsson Funk, Jennifer E Flythe
Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis. Journal of the American Society of Nephrology : JASN (2024)
Sherine Ismail, Michele Jonsson Funk, Jennifer E Flythe
Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis. Journal of the American Society of Nephrology : JASN 35 (8) (2024)
Sherine Ismail, Michele Jonsson Funk, Jennifer E Flythe
Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis. Journal of the American Society of Nephrology : JASN 35 (8) (2024)
Sherine Ismail, Michele Jonsson Funk, Jennifer E Flythe
Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis. Journal of the American Society of Nephrology : JASN 35 (8) (2024)
Sherine Ismail, Laila Abu Esba, Mansoor Khan, Hana Alabdulkarim, Hind Modimagh, Consuela Yousef
An Institutional Guide for Formulary Decisions of Biosimilars. Hospital pharmacy 58 (1) (2022)
Sherine Ismail, Laila Abu Esba, Mansoor Khan, Hana Alabdulkarim, Hind Modimagh, Consuela Yousef
An Institutional Guide for Formulary Decisions of Biosimilars. Hospital pharmacy 58 (1) (2022)
Reem Almutairy, Waad Aljrarri, Afnan Noor, Pansy Elsamadisi, Nour Shamas, Mohammad Azfar Qureshi, Sherine Ismail
Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia. Antibiotics (Basel, Switzerland) 9 (8) (2020)
Sherine Ismail, Abrar Al-Subhi, Eman Youssif, Medhat Ahmed, Abdullah Almalki, Diane L Seger, Andrew C Seger, Earl Cook
Patient-centered Pharmacist Care in the Hemodialysis Unit: a quasi-experimental interrupted time series study. BMC nephrology 20 (1) (2019)
Abrar F Alhameed, Sara Al Khansa, Hani Hasan, Sherine Ismail, Mohammed Aseeri
Bridging the Gap between Theory and Practice; the Active Role of Inpatient Pharmacists in Therapeutic Drug Monitoring. Pharmacy (Basel, Switzerland) 7 (1) (2019)
Majed Alshamrani, Abdullah Almalki, Mohamed Qureshi, Oyindamola Yusuf, Sherine Ismail
Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing. Pharmacy (Basel, Switzerland) 6 (3) (2018)
Sherine Ismail, Mohamed Osman, Rayf Abulezz, Hani Alhamdan, K H Mujtaba Quadri
Pharmacists as Interprofessional Collaborators and Leaders through Clinical Pathways. Pharmacy (Basel, Switzerland) 6 (1) (2018)